Bill116th CongressFiled Feb 13, 2019Health
H.R. 1188
FLAT Prices Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Feb 13, 2019)
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
What just happenedFeb 14, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Golden, Jared F. [D-ME-2](D-ME)Sponsor
7 cosponsors7 D
7cosponsors1committees4actions1related bills7subjects
- Introduced in HouseFeb 13, 2019
- Feb 14, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 13, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 13, 2019IntroReferralIntro-H
Introduced in House
- Feb 13, 2019IntroReferral1000
Introduced in House